Skip to Content
Merck
  • [Possibility of preventing muscular dystrophy in E avitaminosis with alpha-tocopheronolactone and diludin].

[Possibility of preventing muscular dystrophy in E avitaminosis with alpha-tocopheronolactone and diludin].

Voprosy pitaniia (1982-03-01)
V N Kovalenko, G V Donchenko, I V Kuz'menko, N M Gurina, V P Makovetskiĭ
ABSTRACT

The efficacy of pharmacopeial alpha-tocopheryl acetate, alpha-tocopheronolactone and the antioxidant diludin was studied as to the possibilities of preventing E-hypovitaminosis muscle dystrophy in rabbits. alpha-Tocopheronolactone action was similar to that of pharmacopeial alpha-tocopheryl acetate as regards E-vitamin activity that was manifested by an increase in the body mass, decrease in the urine creatine index and maintenance of normal ubiquinone content, as well as of succinate-ubiquinone-reductase, NADH-ubiquinone-reductase and NADH-cytochrome c-reductase activity of rabbit skeletal muscle and heart mitochondria. On the contrary , as a result of the antioxidant administration, no direct correlation was found between ubiquinone content and activity of ubiquinone-dependent enzymatic systems of mitochondria. The data obtained attest to high E-vitamin activity of alpha-tocopheronolactone. The action of the latter was disclosed to be different from that produced by the antioxidant.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Diethyl 1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate, 95%